We performed examinations to establish OS estimates as a function of the PD-L1 and PD-L2 expression on mDCs, pDCs, and MO/MA in PB, PF, and tumor tissue from ovarian cancer patients. This evidence concerns the gene PDCD1LG2 and neoplasm.